GENEVA, Dec. 21 -- SHANGHAI INNOGEN PHARMACEUTICAL TECHNOLOGY CO., LTD. (Room 201/202/203/204, Building 1, No.720 Cailun Road, Pilot Free Trade ZonePudong New Area, Shanghai 201203), 上海银诺医药技术有限公司 (中国上海市浦东新区自由贸易试验区蔡伦路720弄1号楼201、202、203、204室) filed a patent application (PCT/CN2025/100586) for "FUSION PROTEIN CONTAINING IMPROVED GLP-1 POLYPEPTIDE AND USE" on Jun 12, 2025. With publication no. WO/2025/256577, the details related to the patent application was published on Dec 18, 2025...